EVENT INFORMATION

- This is a Online Live Broadcast
- Upon registration, a confirmation will be provided via email
- Within 3 days of the conference, login instructions will be provided via email
- PALLIATIVE CARE PROGRAM: Following the conclusion of the Healthcare Professional program, a Patient-Centered non-CME forum is being held on April 30, 2022 from 3:30-5:00pm. CLICK HERE: To attend and share this opportunity with the patients, spouses, caregivers and survivors you know and have treated.
Next quote »
"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."
-Makenzi Evangelist, M.D., New York Oncology Hematology
“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."
-Nischala Ammannagari, M.D., New York Oncology Hematology
Registration
Conference Platform
PROGRAM OVERVIEW
EDUCATIONAL GOAL
TARGET AUDIENCE
LEARNING OBJECTIVES
After completing this activity, participants will be able to:
- Evaluate the optimal perioperative treatment approaches in the management of gastrointestinal cancers.
- Discuss updated data on novel agents and therapeutic approaches for patients with metastatic gastrointestinal cancers.
- Analyze the role of molecular biomarkers and indicated testing strategies in the care of patients with gastrointestinal malignancies.
- Discuss surgical management options of liver metastases in colorectal cancers and locoregionally advanced appendix cancer.
- Understand the role and indications of Interventional Radiologic treatment modalities in gastrointestinal malignancies.